Discussions

Whole exome sequencing (WES) is particularly useful for patients seeking a comprehensive diagnosis for multiple medical issues. With years of expertise in next-generation sequencing (NGS), Creative Biolabs has developed the state-of-the-art SuPrecision™ platform for NGS services. WES, combined with our extensive bioinformatics pipeline, is an effective tool for analyzing a person's exome, especially in cancer patients. We leverage our advanced platform and vast experience to provide top-quality WES services tailored to meet the specific needs of our customers.

Cancer exome sequencing
Creative Biolabs, equipped with world-leading technology platforms and a team of professional scientists, has extensive experience in conducting WES and providing comprehensive bioinformatics analysis. Our WES workflow includes 1) experimental design, 2) library preparation and exome enrichment, 3) sequencing, and 4) variant calling and downstream analysis. We accept various starting materials for WES projects, including purified genomic DNA, frozen cell pellets, and formalin-fixed paraffin-embedded (FFPE) thin tissue sections (slides).